244 related articles for article (PubMed ID: 10882714)
1. Age-dependent defect in vascular endothelial growth factor expression is associated with reduced hypoxia-inducible factor 1 activity.
Rivard A; Berthou-Soulie L; Principe N; Kearney M; Curry C; Branellec D; Semenza GL; Isner JM
J Biol Chem; 2000 Sep; 275(38):29643-7. PubMed ID: 10882714
[TBL] [Abstract][Full Text] [Related]
2. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1.
Forsythe JA; Jiang BH; Iyer NV; Agani F; Leung SW; Koos RD; Semenza GL
Mol Cell Biol; 1996 Sep; 16(9):4604-13. PubMed ID: 8756616
[TBL] [Abstract][Full Text] [Related]
3. Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase.
Gleadle JM; Ratcliffe PJ
Blood; 1997 Jan; 89(2):503-9. PubMed ID: 9002952
[TBL] [Abstract][Full Text] [Related]
4. Stabilization of vascular endothelial growth factor mRNA by hypoxia-inducible factor 1.
Liu LX; Lu H; Luo Y; Date T; Belanger AJ; Vincent KA; Akita GY; Goldberg M; Cheng SH; Gregory RJ; Jiang C
Biochem Biophys Res Commun; 2002 Mar; 291(4):908-14. PubMed ID: 11866451
[TBL] [Abstract][Full Text] [Related]
5. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines.
Jones A; Fujiyama C; Blanche C; Moore JW; Fuggle S; Cranston D; Bicknell R; Harris AL
Clin Cancer Res; 2001 May; 7(5):1263-72. PubMed ID: 11350893
[TBL] [Abstract][Full Text] [Related]
6. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
7. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
Blancher C; Moore JW; Robertson N; Harris AL
Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
[TBL] [Abstract][Full Text] [Related]
8. Mersalyl is a novel inducer of vascular endothelial growth factor gene expression and hypoxia-inducible factor 1 activity.
Agani F; Semenza GL
Mol Pharmacol; 1998 Nov; 54(5):749-54. PubMed ID: 9804609
[TBL] [Abstract][Full Text] [Related]
9. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.
Rapisarda A; Uranchimeg B; Scudiero DA; Selby M; Sausville EA; Shoemaker RH; Melillo G
Cancer Res; 2002 Aug; 62(15):4316-24. PubMed ID: 12154035
[TBL] [Abstract][Full Text] [Related]
10. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia.
Salnikow K; Kluz T; Costa M; Piquemal D; Demidenko ZN; Xie K; Blagosklonny MV
Mol Cell Biol; 2002 Mar; 22(6):1734-41. PubMed ID: 11865053
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-inducible factor 1 regulates vascular endothelial growth factor expression in human pancreatic cancer.
Büchler P; Reber HA; Büchler M; Shrinkante S; Büchler MW; Friess H; Semenza GL; Hines OJ
Pancreas; 2003 Jan; 26(1):56-64. PubMed ID: 12499918
[TBL] [Abstract][Full Text] [Related]
12. Activator-protein-1 binding potentiates the hypoxia-induciblefactor-1-mediated hypoxia-induced transcriptional activation of vascular-endothelial growth factor expression in C6 glioma cells.
Damert A; Ikeda E; Risau W
Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):419-23. PubMed ID: 9359410
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia-inducible factor-1 alpha is regulated at the post-mRNA level.
Wenger RH; Kvietikova I; Rolfs A; Gassmann M; Marti HH
Kidney Int; 1997 Feb; 51(2):560-3. PubMed ID: 9027739
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide.
Kimura H; Weisz A; Kurashima Y; Hashimoto K; Ogura T; D'Acquisto F; Addeo R; Makuuchi M; Esumi H
Blood; 2000 Jan; 95(1):189-97. PubMed ID: 10607702
[TBL] [Abstract][Full Text] [Related]
15. Synergistic cooperation between hypoxia and transforming growth factor-beta pathways on human vascular endothelial growth factor gene expression.
Sánchez-Elsner T; Botella LM; Velasco B; Corbí A; Attisano L; Bernabéu C
J Biol Chem; 2001 Oct; 276(42):38527-35. PubMed ID: 11486006
[TBL] [Abstract][Full Text] [Related]
16. Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase.
Görlach A; Diebold I; Schini-Kerth VB; Berchner-Pfannschmidt U; Roth U; Brandes RP; Kietzmann T; Busse R
Circ Res; 2001 Jul; 89(1):47-54. PubMed ID: 11440977
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
[TBL] [Abstract][Full Text] [Related]
18. Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cells.
Post DE; Van Meir EG
Gene Ther; 2001 Dec; 8(23):1801-7. PubMed ID: 11803400
[TBL] [Abstract][Full Text] [Related]
19. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of vascular endothelial growth factor expression in a rat glioma is conferred by two distinct hypoxia-driven mechanisms.
Damert A; Machein M; Breier G; Fujita MQ; Hanahan D; Risau W; Plate KH
Cancer Res; 1997 Sep; 57(17):3860-4. PubMed ID: 9288800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
